ACCELERON PHARMA INC's ticker is XLRN and the CUSIP is 00434H108. A total of 8 filers reported holding ACCELERON PHARMA INC in Q3 2013. The put-call ratio across all filers is - and the average weighting 0.1%.
Quarter-by-quarter ownership
Value | Shares | Weighting | ||||
---|---|---|---|---|---|---|
Q3 2021 | $17,210,000 | +174.3% | 100,000 | +100.0% | 0.21% | +195.8% |
Q2 2021 | $6,275,000 | -8.2% | 50,000 | -0.8% | 0.07% | -18.2% |
Q1 2021 | $6,838,000 | +144.3% | 50,423 | -32.8% | 0.09% | +319.0% |
Q3 2017 | $2,799,000 | +76.8% | 75,000 | +25.0% | 0.02% | +40.0% |
Q1 2016 | $1,583,000 | +1.7% | 60,000 | -14.3% | 0.02% | -76.6% |
Q3 2013 | $1,556,000 | – | 70,000 | – | 0.06% | – |
Download |
Other shareholders
Name | Shares | Value | Weighting ↓ |
---|---|---|---|
Foresite Capital Management III, LLC | 42,030 | $3,777,000 | 6.01% |
Artal Group S.A. | 1,500,000 | $134,805,000 | 5.70% |
GREAT POINT PARTNERS LLC | 535,627 | $48,137,000 | 5.03% |
KINGDON CAPITAL MANAGEMENT, L.L.C. | 211,038 | $18,966,000 | 3.47% |
Cormorant Asset Management, LP | 825,000 | $74,143,000 | 3.44% |
Graticule Asia Macro Advisors LLC | 48,700 | $4,377,000 | 3.20% |
Avoro Capital Advisors LLC | 860,000 | $77,288,000 | 2.61% |
QVT Financial LP | 120,264 | $10,808,000 | 2.52% |
Ikarian Capital, LLC | 316,900 | $28,480,000 | 2.14% |
Avidity Partners Management LP | 166,000 | $14,918,000 | 2.06% |